首页> 外国专利> (6S,9aS)-N-BENZYL-6-(4-HYDROXYPHENYL)METHYL-4,7-DIOXO-8-({6-3-(PIPERAZINE-1-YL)AZETIDINE-1-YLPYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO2,1-c1,2,4TRIAZINE-1-CARBOXAMIDE COMPOUND

(6S,9aS)-N-BENZYL-6-(4-HYDROXYPHENYL)METHYL-4,7-DIOXO-8-({6-3-(PIPERAZINE-1-YL)AZETIDINE-1-YLPYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO2,1-c1,2,4TRIAZINE-1-CARBOXAMIDE COMPOUND

机译:(6S,9aS)-N-苄基-6-[(4-羟基苯甲基)甲基] -4,7-二氧-8-({6- [3-(哌嗪-1-基)氮杂环丁烷-1-基]吡啶-2-YL}甲基)-2-(PROP-2-EN-1-YL)-八氢-1H-吡嗪并[2,1-c] [1,2,4]三嗪-1-甲酰胺化合物

摘要

Provided is a compound represented by general formula (1) or a pharmaceutically acceptable salt thereof. In the formula, R1 refers to а C1-6 alkyl group; R2 and R3 are the same or different, and refer to a hydrogen atom or a C1-6 alkyl group; X2, X3, and X4 are the same or different, and refer to a hydrogen atom or halogen atom; and X5 refers to a hydrogen atom, -P(=O)(OH)2.
机译:提供由通式(1)表示的化合物或其药学上可接受的盐。式中,R 1表示C 1-6烷基。 R 2和R 3相同或不同,表示氢原子或碳数1〜6的烷基。 X 2,X 3和X 4相同或不同,是指氢原子或卤素原子; X5是氢原子-P(= O)(OH)2。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号